News
3T Biosciences Strengthens Leadership Team with Promotion of Marvin Gee, Ph.D., to Chief Research Officer and Appointment of Barbara Sennino, Ph.D., as Senior Vice President and Head of Early Development
3T Biosciences Builds Transatlantic Pan-Cancer Research Pipeline to Target Most Difficult-to-Treat Cancers
Boehringer Ingelheim and 3T Biosciences enter into a second partnership to develop next-generation cancer immunotherapies
Publications
- 3T Platform & TCR Profiling
- Target Identification for Autoimmune Disease
- Target Identification for Oncology Indications
Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro
Proceedings of the National Academy of Sciences (PNAS)
T cell receptor cross-reactivity expanded by dramatic peptide/MHC adaptability
Nature Chemical Biology
Intracellular targets as source for cleaner targets for the treatment of solid tumors
Biochemical Pharmacology
